This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hoffman GS et al. (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488–498
Lapraik C et al. (2007) BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 46: 1615–1616
Metzler C et al. (2007) Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) 46: 1087–1091
Villa-Forte A et al. (2007) Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience. Medicine (Baltimore) 86: 269–277
De Groot K et al. (2005) Randomised controlled trial of daily oral versus pulsed cyclophosphamide for induction of remission in ANCA associated systemic vasculitis (abstract). Kidney Blood Press Res 28: 195
Finkielman JD et al. (2007) Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med 147: 611–619
Kerr GS et al. (1993) Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36: 365–371
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Villa-Forte, A., Hoffman, G. Discussion of the 2007 British Society for Rheumatology guidelines for management of ANCA-associated vasculitis. Nat Rev Rheumatol 4, 284–285 (2008). https://doi.org/10.1038/ncprheum0804
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0804